Report
26 Jan 2012
Fact sheet 5: Improving pandemic preparedness
Read more
Report
26 Jan 2012
Fact sheet 4: Benefits of healthcare worker immunization
Read more
Report
26 Jan 2012
Fact sheet 3: Economic benefits of immunization
Read more
Report
26 Jan 2012
Fact sheet 2: Influenza risk groups
Read more
Report
26 Jan 2012
Fact sheet 1: Public health benefits of immunization
Read more
Report
26 Jan 2012
Improving global health through pharmaceutical innovation
Read more
Report
26 Jan 2012
IFPMA code of practice (2012)
Read more
Report
26 Jan 2012
Ending neglected tropical diseases 2012 IFPMA member companies support eliminating and controlling neglected tropical diseases over the next decade through landmark donations
Read more
Statement
20 Jan 2012
Agenda item 6.11, “Elimination of schistosomiasis” at the 130th Executive Board of the World Health Organization
130th Executive Board of the World Health Organization IFPMA Statement under agenda item 6.11, “Elimination of Schistomiasis” Remarks by Mario Ottiglio, Associate Director, Global Health Policy and Public Affairs Mr. Chairman, Madam Director General, distinguished members of the Executive Board, Excellencies, ladies and gentlemen, Thank you for the opportunity to input on the important discussions...
Read more
Video
5 Jan 2012
Video Part 1 by Tim Wilsdon, Charles River Associates
IFPMA Geneva Pharma Forum: Access to antiretrovirals in developing countries: towards a new landscape?
Read more
Video
5 Jan 2012
Video Part 2 by Tim Wilsdon, Charles River Associates
IFPMA Geneva Pharma Forum: Access to antiretrovirals in developing countries: towards a new landscape?
Read more
Video
5 Jan 2012
Video Part 3 by Tim Wilsdon, Charles River Associates
IFPMA Geneva Pharma Forum: Access to antiretrovirals in developing countries: towards a new landscape?
Read more